deltatrials
Completed NA INTERVENTIONAL 2-arm NCT02084381

PERCI- Medium Cut Off (MCO) (PERCI-MCO)

Permeability Enhancement to Reduce Chronic Inflammation _ Medium Cut Off (MCO) (Study no 1502)

Sponsor: Baxter Healthcare Corporation

Conditions Chronic Inflammation Chronic Kidney Failure
Interventions MCO-Ci 400 Revaclear 400
Updated 8 times since 2017 Last updated: Mar 11, 2025 Started: Feb 28, 2014 Primary completion: Jul 31, 2014 Completion: Feb 28, 2015
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02084381, this NA trial focuses on Chronic Inflammation and Chronic Kidney Failure and remains completed. Sponsored by Baxter Healthcare Corporation, it has been updated 8 times since 2014, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~May 2017 · 4 months · monthly snapshotCompleted~May 2017 – ~Jun 2018 · 13 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Mar 2022 · 14 months · monthly snapshotCompleted~Mar 2022 – ~Jul 2024 · 28 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Apr 2025 · 7 months · monthly snapshotCompleted~Apr 2025 – present · 15 months · monthly snapshotCompleted

Change History

8 versions recorded

  1. Apr 2025 — Present [monthly]

    Completed NA

  2. Sep 2024 — Apr 2025 [monthly]

    Completed NA

  3. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  4. Mar 2022 — Jul 2024 [monthly]

    Completed NA

  5. Jan 2021 — Mar 2022 [monthly]

    Completed NA

▶ Show 3 earlier versions

  1. Jun 2018 — Jan 2021 [monthly]

    Completed NA

  2. May 2017 — Jun 2018 [monthly]

    Completed NA

  3. Jan 2017 — May 2017 [monthly]

    Completed NA

    First recorded

Feb 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Baxter Healthcare Corporation
  • Gambro Dialysatoren GmbH
  • German Federal Ministry of Education and Research
  • Vantive Health LLC
Data source: Vantive Health LLC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations